Organigram (OGI) Set to Announce Quarterly Earnings on Tuesday

Organigram (NASDAQ:OGI) is set to post its quarterly earnings results before the market opens on Tuesday, August 13th. Analysts expect Organigram to post earnings of ($0.05) per share for the quarter.

Organigram (NASDAQ:OGI) last posted its quarterly earnings data on Tuesday, May 14th. The company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.06). The company had revenue of $27.91 million for the quarter, compared to analyst estimates of $28.27 million. Organigram had a negative net margin of 188.38% and a negative return on equity of 40.19%. On average, analysts expect Organigram to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Organigram Stock Performance

OGI opened at $1.55 on Wednesday. The firm has a 50 day moving average price of $1.61 and a 200 day moving average price of $1.86. The company has a market cap of $160.89 million, a PE ratio of -1.63 and a beta of 1.06. Organigram has a 1 year low of $0.97 and a 1 year high of $2.91.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on OGI shares. Alliance Global Partners raised shares of Organigram from a “neutral” rating to a “buy” rating in a research report on Monday, April 15th. Canaccord Genuity Group started coverage on shares of Organigram in a research report on Wednesday, July 17th. They set a “speculative buy” rating for the company.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.